Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia

Intensive Care Medicine

Volumn 27, Issue 2, 2001, Pages 355-362

  Dupont, H ^a   Mentec, H ^b   Sollet, J P ^b   Bleichner, G ^b  

^a BICHAT HOSPITAL   (France)

^b CENTRE HOSPITALIER VICTOR DUPOUY   (France)

Author keywords

Initial antibiotic therapy; Mortality; Ventilator associated pneumonia

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFOTAXIME; CEFPIROME; CEFTRIAXONE; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; ISEPAMICIN; NETILMICIN; OFLOXACIN; OXACILLIN; PEFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; TREATMENT OUTCOME; VENTILATOR;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 0035088904     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340000640     Document Type: Article

References (33)

1. Nosocomial infections in elderly patients in the United States, 1986-1990. National Nosocomial Infections Surveillance System
2. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study
3. Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies
4. Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay
5. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient
6. Effect of ventilator-associated pneumonia on mortality and morbidity
7. Ventilator-associated pneumonia due to Pseudomonas aeruginosa
8. The effect of late-onset ventilator-associated pneumonia in determining mortality
9. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia
10. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria
11. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy
12. Septic shock in bacteremic patients: Risk factors, features and prognosis
13. Inadequate antimicrobial treatment of infections. A risk factor for hospital mortality among critically ill patients
14. Nosocomial pneumonia: A multivariate analysis of risk and prognosis
15. The influence of mini-BAL cultures on patient outcomes
16. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients
17. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit
18. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia
19. Impact of invasive and non-invasive quantitative culture sampling of ventilator-associated pneumonia
20. Patient selection for clinical investigation of ventilator-associated pneumonia. Criteria for evaluating diagnostic techniques
21. Diagnosis of nosocomial pneumonia in mechanically ventilated patients. Comparison of a plugged telescoping catheter with the protected specimen brush
22. Use of a bronchoscopic protected catheter brush for the diagnosis of pulmonary infections
23. Protected bronchoalveolar lavage. A new bronchoscopic technique to retrieve uncontaminated distal airway secretions
24. Communiqué 1996
25. A new simplified acute physiologic score (SAPS II) based on a European-North American multicenter study
26. Complications of assisted ventilation. A prospective study of 354 consecutive episodes
27. Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunction and/or infection
28. Nosocomial pneumonia in patients receiving continuous mechanical ventilation
29. The value of routine microbial investigation in ventilator-associated pneumonia
30. Diagnostic accuracy of protected specimen brush and bronchoalveoalar lavage in nosocomial pneumonia: Impact of previous antimicrobial treatments
31. Multivariable pronostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
32. Survival in patients with nosocomial pneumonia: Impact of the severity of illness and the etiologic agent
33. Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia